We enforce our commitment to these balanced principles by helping clients develop sensible laws, regulations, and policies that ensure pharmaceutical controlled substances are not diverted or abused while also protecting their legitimate use.
Our Policy Expertise
Our team includes the former head of the DEA Diversion Control Program, a former DEA attorney and senior policy advisor, and a former DEA Diversion Program Manager, all of whom have substantial hands-on experience in controlled substance-related legislation and policy development. For decades, we provided substantive and technical assistance to Congress in the federal legislative process, and we advised state and local jurisdictions and related stakeholders on legislation, regulations, policies, and related actions concerning drug regulation and control. This makes us uniquely capable of collaborating with our clients on how to effectively prevent diversion and abuse of pharmaceutical controlled substances, while also accommodating their legitimate use, through legislation, regulations, and policies.
The depth and breadth of our experience also allow us to provide expert analysis of proposed laws and regulations and their potential impact on pharmaceutical drug diversion, as well as their potential impact on healthcare providers and others in the pharmaceutical supply chain.
801 Consulting | Policy Development & Support
At 801 Consulting, we provide strategic, informed expert advice on how to effectively prevent diversion of pharmaceutical controlled substances through legislation, regulations, and policies while being supportive of their legitimate medical use. If you need expert, non-partisan analysis and consultation, contact us by filling out our online form today